GLP-1 receptor agonists and risk for cirrhosis and related complications in patients with metabolic dysfunction-associated steatotic liver disease
Kanwal F, Kramer JR, Li L, et al.
JAMA Intern Med. Pub. online 16 Sep 2024.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Risk factors for Charcot foot development in individuals with diabetes mellitus
Tsatsaris G, Rajamand Ekberg N, Fall T, Catrina SB
Diabetologia. Pub. online 13 Sep 2024.
Leggi
Association between personality, lifestyle behaviors, and cardiovascular diseases in type 2 diabetes mellitus: a population-based cohort study of UK Biobank data
Park CS, Choi J, Kwak S, et al.
BMJ Open Diabetes Res Care. Pub. online 10 Sep 2024.
Leggi
Prediction of gestational diabetes mellitus by multiple biomarkers at early gestation
Yang MN, Zhang L, Wang WJ, et al.
BMC Pregnancy Childbirth. Pub. online 16 Sep 2024.
Leggi
The association between macrosomia and glucose, lipids and hormones levels in maternal and cord serum: a case-control study
Xing X, Duan Y, Wang J, et al.
BMC Pregnancy Childbirth. Pub. online 14 Sep 2024.
Leggi
The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial
Elbarbary NS, Ismail EA, El-Hamamsy MH, et al.
Diabetologia. Pub. online 14 Sep 2024.
Leggi
Readiness for behaviour change after gestational diabetes mellitus: a prospective cohort study
Sarma S, Bhatia D, Yu C, et al.
Diabet Med. Pub. online 14 Sep 2024.
Leggi
Pathophysiology and treatment of prediabetes and type 2 diabetes in youth
Bacha F, Hannon TS, Tosur M, et al.
Diabetes Care. Pub. online 9 Sep 2024.
Leggi
Increased incidence of neurodegenerative diseases in Finnish individuals with type 1 diabetes
Satuli-Autere S, Harjutsalo V, Eriksson MI, et al.
BMJ Open Diabetes Res Care. Pub. online 5 Sep 2024.
Leggi
Safety of options to “Boost” (Enhancing Insulin Infusion Rates) and “Ease-Off” (Reducing Insulin Infusion Rates) in CamAPS FX hybrid closed-loop system: a real-world analysis
Royston C, Bergford S, Calhoun P, et al.
Diabetes Technol Ther. Pub. online 9 Sep 2024.
Leggi